AChE Antibodies

Santa Cruz Biotechnology features a diverse variety of AChE Antibodies for research focused on understanding acetylcholinesterase in biological processes. AChE Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Acetylcholinesterase is a critical enzyme responsible for the hydrolysis of the neurotransmitter acetylcholine, playing a vital role in synaptic transmission and muscle contraction. Proper functioning of acetylcholinesterase is essential for maintaining neuromuscular health and cognitive processes. Dysregulation of acetylcholinesterase activity has been implicated in various neurological disorders, including Alzheimer's disease and myasthenia gravis. Research utilizing AChE monoclonal antibodies can provide valuable insights into these conditions and aid in the development of therapeutic strategies. Understanding acetylcholinesterase dynamics through molecular and cellular studies helps advance knowledge of neurodegenerative diseases. AChE monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to neuroscience and therapeutic development.